Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 686.06

+1.6%

1:39 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bocaburgerman who wrote (247)	10/30/1998 10:50:00 PM
From: geewiz	Read Replies (1) of 3557

Winston, I located your post with a search for "angiogenesis". NBC did a brief interesting story on use of angiogenesis to stimulate cardiovascular vessel growth as an alternative to angioplasty. This potential market is significant. Cardiovascular care is the leading expense of HMO's and despite the reluctance of MD's to change routines, the cost factor may dictate a shift once the method is proven successful. I am not familiar with Regeneron; I will read the thread this weekend. Here is a link to the NBC story, to view the clip a download may be necessary. msnbc.com best,art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next